Skip to content
10-K/A

Annual Report

Galileo Life Sciences, Inc.

0001199835-14-000599

← back to feed
Filed
Nov 20, 2014 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.

On SEC.gov

Financials in this filing

Metric Period Value
Operating Cash Flow FY 2014 · Jun 30, 2014 −291.89K
Operating Cash Flow FY 2014 · Jun 30, 2013 −58.77K
Stockholders Equity FY 2014 · Jun 30, 2014 −667.05K
Stockholders Equity FY 2014 · Jun 30, 2013 −519.77K
Stockholders Equity FY 2014 · Jun 30, 2012 −467.17K
Current Liabilities FY 2014 · Jun 30, 2014 725.47K
Current Liabilities FY 2014 · Jun 30, 2013 519.77K
Total Liabilities FY 2014 · Jun 30, 2014 725.47K
Total Liabilities FY 2014 · Jun 30, 2013 519.77K
Current Assets FY 2014 · Jun 30, 2014 12.41K
Current Assets FY 2014 · Jun 30, 2013 0
Total Assets FY 2014 · Jun 30, 2014 58.42K
Total Assets FY 2014 · Jun 30, 2013 0
Sga Expense FY 2014 · Jun 30, 2014 20.12K
Sga Expense FY 2014 · Jun 30, 2013 80
Net Income FY 2014 · Jun 30, 2014 −248.24K
Net Income FY 2014 · Jun 30, 2013 −52.6K
Operating Income FY 2014 · Jun 30, 2014 −271.37K
Operating Income FY 2014 · Jun 30, 2013 −55.22K
Gross Profit FY 2014 · Jun 30, 2014 0
Gross Profit FY 2014 · Jun 30, 2013 0
Cost Of Revenue FY 2014 · Jun 30, 2014 0
Cost Of Revenue FY 2014 · Jun 30, 2013 0
Revenue FY 2014 · Jun 30, 2014 0
Revenue FY 2014 · Jun 30, 2013 0
Shares Outstanding FY 2014 · Jun 2, 2014 195.48M sh